Viewing Study NCT03927105

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-03-03 @ 2:37 AM
Study NCT ID: NCT03927105
Status: COMPLETED
Last Update Posted: 2024-03-18
First Post: 2019-04-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
Sponsor: University of Michigan Rogel Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral T Cell Lymphoma View
Keywords: